Valuation: Cegedim

Market Cap 140M 159M 131M 120M 225M 15.29B 229M 1.55B 605M 7.56B 599M 586M 26.13B P/E 2026 *
6.69x
P/E 2027 * 5.1x
Enterprise Value 302M 344M 282M 259M 485M 32.99B 493M 3.33B 1.31B 16.32B 1.29B 1.26B 56.39B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 2009-10-24
Director of Finance/CFO - 2016-06-13
Corporate Officer/Principal 55 2015-11-25
Director TitleAgeSince
Chairman 83 2009-10-24
Director/Board Member 72 2010-08-08
Director/Board Member 55 2009-10-25
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 158M
+0.05%-1.17%-51.06%+3.06% 345B
+5.26%+15.17%-35.00%+29.15% 199B
+4.79%+5.65%-42.91%-1.21% 109B
+6.45%+8.62%-38.24%+9.90% 42.61B
-2.52%-1.70%-76.31%+125.65% 35.43B
+4.35%+5.73%-12.81%+62.89% 29.7B
+4.86%+4.83%-33.59%+52.12% 17.88B
+4.68%+9.72%-31.51%+9.41% 13B
+6.78%+6.84%-28.64%+98.09% 12.43B
Average +3.24%+2.01%-38.90%+43.23% 89.35B
Weighted average by Cap. +2.01%+2.19%-43.96%+19.56%

Financials

2026 *2027 *
Net sales 660M 751M 615M 565M 1.06B 72B 1.08B 7.28B 2.85B 35.61B 2.82B 2.76B 123B 684M 779M 638M 586M 1.1B 74.67B 1.12B 7.55B 2.96B 36.93B 2.92B 2.86B 128B
Net income 21.3M 24.26M 19.87M 18.25M 34.21M 2.33B 34.77M 235M 92.04M 1.15B 91.06M 89.1M 3.97B 28M 31.89M 26.12M 23.99M 44.97M 3.06B 45.71M 309M 121M 1.51B 120M 117M 5.22B
Net Debt 162M 185M 151M 139M 260M 17.7B 265M 1.79B 701M 8.75B 693M 678M 30.25B 134M 152M 125M 115M 215M 14.6B 218M 1.48B 578M 7.22B 572M 560M 24.96B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-